Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2
Clinical trial NCT02733159 · COMPLETED
Trial details
- NCT number
- NCT02733159
- Sponsor
- University of Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-04
- Primary completion
- 2023-02-07
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.